2007
DOI: 10.1016/j.neuropharm.2006.10.010
|View full text |Cite
|
Sign up to set email alerts
|

Nalfurafine, the kappa opioid agonist, inhibits icilin-induced wet-dog shakes in rats and antagonizes glutamate release in the dorsal striatum

Abstract: Icilin, a cooling compound, produces vigorous wet-dog shakes in rats. We have reported previously that icilin-induced wet-dog shakes are blocked by the kappa opioid receptor agonists, nalfurafine and U50,488H, and that icilin evokes a dose-and time-dependent increase in glutamate within the dorsal striatum. Since activation of kappa opioid receptors inhibits glutamate release intrastriatally, we targeted glutamate release within the dorsal striatum using nalfurafine and examined the role of the dorsal striatum… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2008
2008
2013
2013

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 14 publications
(12 citation statements)
references
References 46 publications
0
12
0
Order By: Relevance
“…This idea is supported by the fact that icilin-induced WDS are blocked by central administration of opioids 31, 33, 35, 36, but not by ICI 20448, a peripherally directed kappa opioid agonists 34. Glutamatergic signaling originating in the periphery is required for i.m.…”
Section: Discussionmentioning
confidence: 97%
“…This idea is supported by the fact that icilin-induced WDS are blocked by central administration of opioids 31, 33, 35, 36, but not by ICI 20448, a peripherally directed kappa opioid agonists 34. Glutamatergic signaling originating in the periphery is required for i.m.…”
Section: Discussionmentioning
confidence: 97%
“…Extracellular-regulated protein kinase (ERK) and PIP2 metabolism by PLC activation have been shown to modulate TRPA1 to alter thermal hypersensitivity (Dai et al, 2007; Katsura et al, 2007; Mizushima et al, 2007). Opioid receptor activation antagonizes icilin-induced wet-dog shaking behavior that may be mediated via TRPA1 and/or TRPM8 (Werkheiser et al, 2007). In certain conditions, TRPA1 may be ubiquitinated that may play a role in cancer (Stokes et al, 2006).…”
Section: Transient Receptor Potential Ankyrin 1 (Trpa1)mentioning
confidence: 99%
“…Icilin is a cold-inducing compound that produces a behavioral stimulant effect comprised of WDS, hyperthermia, writhing, and excessive grooming in rats following intraperitoneal injection (Collier, 1974; Wei, 1976, 1981; Collier et al, 1981; Cowan and Watson, 1978; Cowan, 1981; Werkheiser et al, 2006, 2007, 2009; Ding et al, 2008). Consistent with prior work, icilin elicited a dose-dependent increase in shaking behavior in rats in the present experiments.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the potential of TRPM8 ligands as analgesic, antipruritic and antiarthritic agents, the endogenous and exogenous substances that modulate their pharmacological effects in vivo are largely unknown. The trademark overt pharmacological effect of icilin in rats is vigorous wet-dog shakes (WDS) (Wei, 1976, 1981; Werkheiser et al, 2006, 2007, 2009), and this shaking behavior provides a sensitive, reproducible, and quantifiable endpoint to investigate TRPM8 pharmacology in vivo and to identify, and exclude, receptor systems that shape the pharmacological response to TRPM8 channel activation.…”
Section: Introductionmentioning
confidence: 99%